Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: A safe combination

R (Rosa) Hoekstra; FYFL de Vos; Ferry Eskens; EGE de Vries; DRA Uges; R Knight; RA Carr; R Humerickhouse; Jaap Verweij; JA Gietema

doi:10.1016/j.ejca.2005.08.040

Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: A safe combination

R (Rosa) Hoekstra, FYFL de Vos, Ferry Eskens, EGE de Vries, DRA Uges, R Knight, RA Carr, R Humerickhouse, Jaap Verweij, JA Gietema

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

42 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	467-472
Number of pages	6
Journal	European Journal of Cancer
Volume	42
Issue number	4
DOIs	https://doi.org/10.1016/j.ejca.2005.08.040
Publication status	Published - 2006

Research programs

EMC MM-03-86-08

Access to Document

10.1016/j.ejca.2005.08.040

http://hdl.handle.net/1765/67900

Cite this

@article{b633dde16cd4445a9b7d6919f0347deb,

title = "Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: A safe combination",

author = "Hoekstra, {R (Rosa)} and {de Vos}, FYFL and Ferry Eskens and {de Vries}, EGE and DRA Uges and R Knight and RA Carr and R Humerickhouse and Jaap Verweij and JA Gietema",

year = "2006",

doi = "10.1016/j.ejca.2005.08.040",

language = "Undefined/Unknown",

volume = "42",

pages = "467--472",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

number = "4",

}

TY - JOUR

T1 - Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: A safe combination

AU - Hoekstra, R (Rosa)

AU - de Vos, FYFL

AU - Eskens, Ferry

AU - de Vries, EGE

AU - Uges, DRA

AU - Knight, R

AU - Carr, RA

AU - Humerickhouse, R

AU - Verweij, Jaap

AU - Gietema, JA

PY - 2006

Y1 - 2006

U2 - 10.1016/j.ejca.2005.08.040

DO - 10.1016/j.ejca.2005.08.040

M3 - Article

C2 - 16406507

SN - 0959-8049

VL - 42

SP - 467

EP - 472

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 4

ER -